MedTrace Logo

Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

NCT00435019 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2017-03-10

Study results available
· View outcomes & findings →

Summary

This trial is conducted in Europe.

The aim of this research is to compare the efficacy and safety of treatment with NPH insulin and insulin detemir. You will be treated with either insulin detemir or NPH insulin once or twice daily as basal insulin. Additionally you will receive insulin aspart as bolus insulin

Conditions

Interventions

DRUG

insulin detemir

s.c. injection, once or twice daily.

DRUG

insulin NPH

s.c. injection, once or twice daily.

DRUG

insulin aspart

s.c. injection, at main meals.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Bulgaria
  • Czechia
  • Denmark
  • Finland
  • France
  • Hungary
  • North Macedonia
  • Poland
  • Russia
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00435019 on ClinicalTrials.gov